Henry Schein (NASDAQ:HSIC) Announces Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Henry Schein (NASDAQ:HSIC) announced its quarterly earnings results on Tuesday. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09, Briefing.com reports. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.21 earnings per share. Henry Schein updated its FY24 guidance to $5.00 to $5.16 EPS.

Henry Schein Stock Up 1.1 %

Henry Schein stock opened at $68.53 on Tuesday. The stock’s 50 day moving average price is $73.22 and its 200 day moving average price is $72.32. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a market cap of $8.80 billion, a PE ratio of 21.76, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Insiders Place Their Bets

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HSIC shares. Evercore ISI increased their price objective on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. SVB Leerink started coverage on shares of Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price for the company. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.